A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus

NCT01792635 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

19

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated prematurely on 16 May 2014 due to a safety concern.

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: PF-05175157
DRUG: Placebo

Sponsor

Pfizer